Clobazam
Links shared publicly online about this topic
FDA accepts Lundbeck's clobazam NDA for review
news-medical.net — “Lundbeck Inc. today announced the U.S. Food and Drug Administration has accepted for review a New Drug Application for the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome in patients two years and older.” View full resource at news-medical.net
Most Recently Shared on March 5, 2011 at 2:46 pm By:
Epilepsy News: FDA accepts Lundbeck's clobazam NDA for review: Lundbeck Inc. today announced the U.S. Food and D... http://bit.ly/eJKYgJ
FDA Accepts Lundbeck Inc. Submission of New Drug Application for Clobazam
drugs.com — “Onfi (clobazam) is a drug in development for the treatment of Lennox-Gastaut syndrome. Onfi information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on March 9, 2011 at 10:17 pm By:
FDA Accepts Lundbeck Inc. Submission of New Drug Application for Clobazam: DEERFIELD, Ill.--(BUSINESS WIRE... http://bit.ly/hC3xWo #drug
FDA Accepts Lundbeck Inc. Submission Of New Drug Application For Clobazam
medicalnewstoday.com — “Lundbeck Inc. announced the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the investigational compound clobazam as adjunctive therapy in treating” View full resource at medicalnewstoday.com
Most Recently Shared on March 7, 2011 at 12:05 pm By:
FDA Accepts Lundbeck Inc. Submission Of New Drug Application For Clobazam http://mnt.to/3RXv #epilepsy
FDA Accepts Lundbeck's Submission Of The New Drug Application For Clobazam
medicalnewstoday.com — “H. Lundbeck A/S (Lundbeck) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the investigational compound clobazam as adjunctive t” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2011 at 11:05 am By:
FDA Accepts Lundbeck's Submission Of The New Drug Application For Clobazam http://mnt.to/3RWb #epilepsy
FDA Accepts Lundbeck's Submission Of The New Drug Application For Clobazam
medicalnewstoday.com — “H. Lundbeck A/S (Lundbeck) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the investigational compound clobazam as adjunctive t” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2011 at 10:22 pm By:
FDA Accepts Lundbeck's Submission Of The New Drug Application For Clobazam: H. Lundbeck A/S (Lundbeck) announced... http://bit.ly/g9jCvD
FDA Accepts Lundbeck's Submission Of The New Drug Application For Clobazam
medicalnewstoday.com — “H. Lundbeck A/S (Lundbeck) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the investigational compound clobazam as adjunctive t” View full resource at medicalnewstoday.com
Most Recently Shared on March 5, 2011 at 8:57 pm By:
FDA Accepts Lundbeck's Submission Of The New Drug Application For Clobazam: H. Lundbeck A/S (Lundbeck) announced... http://bit.ly/gUQvpG
FDA accepts Lundbeck's submission of the New Drug Application for clobazam
lundbeck.com — “FDA accepts Lundbeck's submission of the New Drug Application for clobazam” View full resource at lundbeck.com
Most Recently Shared on March 4, 2011 at 12:30 pm By:
#FDA accepts @Lundbeck submission of NDA for clobazam http://ow.ly/47OIT
New drug approvals from the FDA: Onfi (clobazam) and generic olanzapine http://t.co/CmOerop6
medicineandtechnology.hcplive.com — “New drug approvals from the FDA: Onfi (clobazam) and generic olanzapine http://t.co/CmOerop6” View full resource at medicineandtechnology.hcplive.com
Most Recently Shared on October 25, 2011 at 2:10 am By:
New drug approvals from the FDA: Onfi (clobazam) and generic olanzapine http://t.co/CmOerop6
Phase 3 study of clobazam for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) - MPR
empr.com — “Lundbeck presented positive data from its Phase 3 study to determine the efficacy and safety profiles of the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome (LGS).” View full resource at empr.com
Most Recently Shared on December 6, 2010 at 8:48 pm By:
MPR News: Phase 3 study of clobazam for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS):... http://bit.ly/glYp5Q
Lundbeck reports positive phase III study data of clobazam in treating seizures associated with LGS
news-medical.net — “Today, Lundbeck Inc. presented positive data from its pivotal phase III study to determine the efficacy and safety profiles of the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome.” View full resource at news-medical.net
Most Recently Shared on December 6, 2010 at 6:40 am By:
Lundbeck reports positive phase III study data of clobazam in treating seizures associated with LGS: Today, Lund... http://bit.ly/fRlCQz
New Drug Application in the Works for Clobazam in Lennox Syndrome - QualityPoint Technologies
qualitypointtech.net — “The largest clinical trial to date of this difficult-to-treat form of childhood-onset epilepsy has returned positive results. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on December 7, 2010 at 4:03 pm By:
New Drug Application in the Works for Clobazam in Lennox Syndrome: The largest clinical trial to date of this diff... http://bit.ly/heENRq
Lundbeck reports positive phase III study results for clobazam in the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome - Drugs.com MedNews
drugs.com — “Data from the pivotal clobazam study were presented at the American Epilepsy Society meeting in San Antonio, TX Two highest dosages of clobazam as add-on therap” View full resource at drugs.com
Most Recently Shared on December 8, 2010 at 3:07 pm By:
Lundbeck reports positive phase III study results for clobazam in the adjunctive treatment of seizures ass... http://bit.ly/e8R9Xl #drug
Lundbeck will submit an NDA for clobazam for patients with Lennox-Gastaut syndrome with the FDA before year end 2010 - News Press Release | PharmiWeb.com
pharmiweb.com — “In March 2009, H. Lundbeck A/S (Lundbeck) acquired Ovation Pharmaceuticals, Inc. (now Lundbeck Inc.). As part of the acquisition Lundbeck obtained the rights for clobazam in the US, a product in development for patients with Lennox-Gastaut syndrom” View full resource at pharmiweb.com
Most Recently Shared on May 25, 2010 at 2:48 pm By:
Press Release: In March 2009, H. Lundbeck A/S (Lundbeck) acquired Ovation Pharmaceuticals, Inc. (now Lundbeck Inc.... http://bit.ly/dlnPTf
FDA Approves Onfi To Treat Severe Type Of Seizures
medicalnewstoday.com — “As of 21st Oct Onfi (clobazam) tablets are FDA (U.S. Food and Drug Administration) approved as an add on treatment for seizures caused by Lennox-Gastaut syndrome in adults and children aged 2 yea” View full resource at medicalnewstoday.com
Most Recently Shared on October 26, 2011 at 12:25 pm By:
FDA Approves Onfi To Treat Severe Type Of Seizures: As of 21st Oct Onfi (clobazam) tablets are FDA (U.S. Food an... http://t.co/8dXStvHb
FDA Approves Onfi To Treat Severe Type Of Seizures
medicalnewstoday.com — “As of 21st Oct Onfi (clobazam) tablets are FDA (U.S. Food and Drug Administration) approved as an add on treatment for seizures caused by Lennox-Gastaut syndrome in adults and children aged 2 yea” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2011 at 4:05 pm By:
FDA Approves Onfi To Treat Severe Type Of Seizures http://t.co/R3A4yQd2 #epilepsy
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Epilepsy news and research via News-Medical.Net
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Epilepsy News
The latest epilepsy news published daily. Articles from research centers, universities and prestigious journals.
Advertisement

